Targeted delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer

Journal of Drug Targeting

Volumn 18, Issue 4, 2010, Pages 277-281

  Taghdisi, Seyed Mohammad ^a   Abnous, Khalil ^a,b   Mosaffa, Fatemeh ^a   Behravan, Javad ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Aptamer; Cell SELEX; Chemotherapy; Daunorubicin; PTK7; T cell acute lymphoblastic leukemia; Targeted delivery; Toxic effect

Indexed keywords

APTAMER; DAUNORUBICIN; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE 7; SGC8; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTINEOPLASTIC AGENTS; APTAMERS, NUCLEOTIDE; BASE SEQUENCE; CELL LINE, TUMOR; DAUNORUBICIN; DRUG DELIVERY SYSTEMS; FLOW CYTOMETRY; HUMANS; NUCLEIC ACID CONFORMATION; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SPECTROMETRY, FLUORESCENCE;

EID: 77951097213     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/10611860903434050     Document Type: Article

References (21)

1. Betancourt T, Brown B, Brannon-Peppas L. (2007). Doxorubicinloaded PLGA nanoparticles by nanoprecipitation: preparation, characterization and in vitro evaluation. Nanomedicine, 2: 219-232.
2. Blank M, Blind M. (2005). Aptamers as tools for target validation. Curr Opin Chem Biol, 9: 336-342.
3. Campbell LK, Scaduto M, Van Slyke D, Niarhos F, Whitlock JA, Compas BE. (2009). Executive function, coping, and behavior in survivors of childhood acute lymphocytic leukemia. J Pediatr Psychol, 34: 317-327.
4. Cerchia L, Ducongé F, Pestourie C, Boulay J, Aissouni Y, Gombert K, Tavitian B, de Franciscis V, Libri D. (2005). Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase. PLoS Biol, 3: 0697-0704. 10.1371/journal.pbio.0030123
5. Davis KA, Lin Y, Abrams B, Jayasena SD. (1998). Staining of cell surface human CD4 with 2?-F-pyrimidine-containing RNA aptamers for flow cytometry. Nucleic Acids Res, 26: 3915-3924.
6. Duan S, Bleibel WK, Huang RS, Shukla SJ, Wu X, Badner JA, Dolan ME. (2007). Mapping genes that contribute to daunorubicin-induced cytotoxicity. Cancer Res, 67: 5425-5433.
7. Fox KR, Webster R, Phelps RJ, Fokt I, Priebe W. (2004). Sequence selective binding of bis-daunorubicin WP631 to DNA. Eur J Biochem, 271: 3556-3566.
8. Huang YF, Shangguan D, Liu H, Phillips JA, Zhang X, Chen Y, Tan W. (2009). Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells. Chembiochem, 10: 862-868.
9. Jain KK. (2005). Editorial: targeted drug delivery for cancer. Technol Cancer Res Treat, 4: 311-313.
10. Kwan JM, Fialho AM, Kundu M, Thomas J, Hong CS, Das Gupta TK, Chakrabarty AM. (2009). Bacterial proteins as potential drugs in the treatment of leukemia. Leuk Res, 33: 1392-1399.
11. Levy-Nissenbaum E, Radovic-Moreno AF, Wang AZ, Langer R, Farokhzad OC. (2008). Nanotechnology and aptamers: applications in drug delivery. Trends Biotechnol, 26: 442-449.
12. Li DC, Zhong XK, Zeng ZP, Jiang JG, Li L, Zhao MM, Yang XQ, Chen J, Zhang BS, Zhao QZ, Xie MY, Xiong H, Deng ZY, Zhang XM, Xu SY, Gao YX. (2009). Application of targeted drug delivery system in Chinese medicine. J Control Release, 138: 103-112.
13. Mojzisová G, Mirossay L, Kucerová D, Kyselovic J, Mirossay A, Mojzis J. (2006). Protective effect of selected flavonoids on in vitro daunorubicin- induced cardiotoxicity. Phytother Res, 20: 110-114.
14. Neidle S. (2008). Principles of Nucleic Acid Structures. Academic Press, London, UK.
15. Phillips JA, Lopez-Colon D, Zhu Z, Xu Y, Tan W. (2008). Applications of aptamers in cancer cell biology. Anal Chim Acta, 621: 101-108.
16. Que-Gewirth NS, Sullenger BA. (2007). Gene therapy progress and prospects: RNA aptamers. Gene Ther, 14: 283-291.
17. Shangguan D, Tang Z, Mallikaratchy P, Xiao Z, Tan W. (2007). Optimization and modifications of aptamers selected from live cancer cell lines. Chembiochem, 8: 603-606.
18. Stoltenburg R, Reinemann C, Strehlitz B. (2007). SELEX-a (r)evolutionary method to generate high-affinity nucleic acid ligands. Biomol Eng, 24: 381-403.
19. Vasir JK, Labhasetwar V. (2005). Targeted drug delivery in cancer therapy. Technol Cancer Res Treat, 4: 363-374.
20. Verdonck LF, Lokhorst HM, Roovers DJ, van Heugten HG. (1998). Multidrug-resistant acute leukemia cells are responsive to prolonged exposure of daunorubicin: implications for liposomeencapsulated daunorubicin. Leuk Res, 22: 249-256.
21. Xiao Z, Shangguan D, Cao Z, Fang X, Tan W. (2008). Cell-specific internalization study of an aptamer from whole cell selection. Chemistry, 14: 1769-1775.